Skip to main content

Contact Gustavo Guimarães Moreira Balbi

From: Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)

Contact corresponding author